Search

everythinglearnresearchcommunity

for

Search:↓

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

New treatments for PCOS focus on managing symptoms and improving fertility.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.